Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Unified Patent Court

- PMLiVE

India turns down patent on Gilead’s Sovaldi

Opens market to cheaper rivals for hepatitis C drug

- PMLiVE

EFPIA promotes pharma’s contribution to Europe

Launches Pharmafigures website to detail industry investment

EU flag

Politically acceptable – a unified patent for Europe

But will Europe’s Unified Patent Court help or harm the pharma sector?

- PMLiVE

Lilly thrown a lifeline on US Alimta patent

Court backs protection from generics until 2022

TxCell plans listing as EU biotech wakes up to IPOs

Move follows UK allergy therapy developer Circassia's listing

- PMLiVE

Pfizer 2014 guidance threatened by Celebrex competition

Court overturns key patent for osteoarthritis drug

mHealth could be ‘the future’ of healthcare

EC says Europe is preparing for the mHealth revolution

- PMLiVE

Roche blocks Herceptin biosimilar in India

Wins court battle after claiming Biocon and Mylan had not followed regulatory criteria

- PMLiVE

Pharma slammed for undermining South African IP reforms

Government criticises leaked strategy to block plans to change patent protection laws

EU flag

MEPs agree clinical trial regulation revision

Paves way for EU trial database and simplified online applications for new studies

- PMLiVE

BIA: Political compromises could undermine EU trial reform

UK biotech body speaks out on eve of crucial committee hearing

- PMLiVE

Pharma should not ignore India

It’s complicated, but multinational pharma cannot ignore a market with one billion plus people

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links